Patients News | pharmaphorum

News

An AI tool could identify colorectal cancer patients most likely to respond to bevacizumab, which was recently backed for NHS use.

News

AstraZeneca's hyperkalaemia drug Lokelma could see its use by the NHS more than double thanks to updated guidance from NICE.

News

Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.

News

Gaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report.

News

AbbVie has opened a new front in the pharma industry's efforts to reform the 340B drug discounting programme for safety net hospitals in the US.

News

Gene variants could explain why some people lose more weight than others with GLP-1 drugs, and why some are more prone to side effects.